Models of unexplained symptoms associated with occupational and environmental exposures. by Spurgeon, Anne
Throughout much of the 20th century the
related fields of occupational and environ-
mental health have been heavily influenced
by what is generally termed the medical
model, a framework that makes a distinction
between disease and nondisease and often
between physically and psychologically based
complaints. The essential concern has been to
examine the relationship between exposure to
suspected hazards and the subsequent devel-
opment of particular forms of ill health. This
approach has been driven both by scientific
methodology and by the political constraints
of risk management and compensation. It has
served occupational and environment medi-
cine extremely well in the past, as evidenced
by the huge reduction in most major indus-
trial diseases during the last 100 years, accom-
panied by a corresponding improvement in
public health. Recently, however, a number
of bafﬂing occupational and environment ill-
nesses have come to the fore that appear to
challenge the traditional model. These ill-
nesses are characterized by a range of chronic
physical, frequently multisystem complaints
that cannot readily be linked physiologically
or toxicologically to a specific hazard expo-
sure, although they are often attributed to
such by the sufferer. For want of a better
descriptor, these conditions tend to be
grouped under such general headings as
“unexplained symptom syndromes,” “func-
tional disorders” (i.e., no pathology), or sim-
ply “symptom-based conditions.” Common
current examples are chronic fatigue syn-
drome (CFS)—sometimes referred to as
myalgic encephalitis—as well as ﬁbromyalgia,
multiple chemical sensitivity, sick building
syndrome, and most recently Gulf War syn-
drome. One might also include some nonspe-
cific, nontraumatic conditions such as
chronic brucellosis and atypical polio. Finally,
a number of conditions involving musculo-
skeletal pain have major unexplained compo-
nents in addition to well-defined ergonomic
risk factors.
However, inspection of medical history
books shows that these syndromes are not
new. Similar conditions have in fact been
reported for many years (1). Only the names
and the attributions appear to change. Note,
for example, “railway spine,” a complaint said
to result from traveling on the newly devel-
oped railway systems, or “telegraphist’s
cramp,” both of which appeared during the
second half of the 19th century. Perhaps not
surprisingly, therefore, the heated debate gen-
erated by these conditions in recent years has
largely failed to resolve questions such as deﬁ-
nition, diagnostic criteria, etiology, and treat-
ment, and the broader issues of risk
assessment and management. This has led
some researchers and clinicians to suggest that
many of the problems associated with investi-
gating these syndromes have arisen because of
a natural but perhaps inappropriate attach-
ment to the medical model (2) that in this
context is proving unhelpful, if not positively
obstructive.
A potentially more fruitful alternative is to
approach the problem from a “biopsycho-
social” standpoint. This position is perhaps
more familiar to psychiatrists, psychologists,
and social workers than to epidemiologists.
Indeed, it was well described and advocated
almost exactly 25 years ago in a seminal paper
by George Engel (3). The biopsychosocial
approach essentially recognizes the complex
interaction between physical and psychologi-
cal processes and views health as a continuum
rather than as a dichotomy between the pres-
ence or absence of disease. Further, illness may
often reflect the personal interpretation of a
condition (real, organic, or otherwise) by the
patient, the doctor, or the therapist rather
than constituting an objectively deﬁned state.
Where unexplained symptom syndromes are
concerned, this approach appears to offer bet-
ter prospects for understanding and manag-
ing ill health than the more traditional
medical paradigm.
However, this said, a number of questions
immediately arise. What exactly do we mean
by a biopsychosocial model in this context?
Are there models and methods that have been
developed in other ﬁelds, notably health psy-
chology, that may have useful application in
occupational and environmental health? The
purpose of this article is to describe such
approaches in the context of a real example of
an occupational health problem that involved
the author’s own research.
What Do We Mean by a
Biopsychosocial Model?
Workers in the ﬁeld of health psychology are
usually careful to make a distinction between
disease and illness, the former being a biologi-
cal event characterized by pathology in the
structure and function of body organs and
systems, and the latter the subjective experi-
ence of negative changes in well-being. This
distinction provides the basis for much
research that is concerned with the nature of
symptom reporting and the response to dis-
ease onset and its treatment. It would appear
to be central to the understanding of un-
explained symptom syndromes because,
implicitly or explicitly, when we adopt a
biopsychosocial position we are concerned
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primarily with the understanding of illness
rather than the explanation of disease. In this
context, disease (or biological factors) repre-
sents just one possible contributor among
many other (largely psychosocial) factors that
help to determine illness or negative changes
in well-being (Figure 1). When we view ill-
ness as the focus of our investigation, there is
much less of a requirement to make poten-
tially unhelpful decisions about whether
something is a “real” disease (hence worthy of
professional attention), or whether it should
be dismissed as “all in the mind.”
It is of course well recognized that
diseases may have multiple contributory
causes. In the past, occupational and envi-
ronmental epidemiology moved rapidly
from a straightforward linear cause–effect
model to one that took account of various
factors with the potential to influence the
outcome of interest. Such factors, often
termed “effect modifiers,” might include
aspects of lifestyle and behavior such as
smoking, alcohol consumption, diet, and
exercise and also some forms of genetic sus-
ceptibility. However, the biopsychosocial
approach can be said to move this approach
one stage further by ascribing a central
rather than a subsidiary role to effect modi-
fiers and also by extending them to include
frankly psychosocial issues such as attitudes
and belief systems.
The reporting of symptoms therefore
represents an outcome of a complex set of
interactions between aspects of personality,
attitudes, culture, and social climate as well
as any pathological changes. Biopsychosocial
models are essentially transactional in nature
in the sense that the various biological, psy-
chological, and social factors serve to contin-
uously reinforce and amplify one another.
This creates considerable difficulties for the
traditional concerns of occupational and
environmental health, namely, quantifying
the risk associated with exposure to certain
physical or chemical hazards, not to mention
its clinical concerns of diagnosis and treat-
ment. However, if it offers a better explana-
tion of some current phenomena, it cannot
be ignored.
Current Models
Work in the field of health psychology has
produced a number of transactional models
that help to explain and predict various
aspects of health-related behavior. Primarily,
these are concerned with the individual’s
response to diagnosis, compliance with treat-
ment regimes, and the maintenance of
health-promoting activities (4,5). As such,
they appear to have direct relevance to the
clinical aspects of occupational and environ-
mental health in terms of management of
problems at the individual case level. For
example, one of the more inﬂuential models
in recent years has been Leventhal’s self-
regulatory model of illness behavior (6),
which describes such behavior as consisting
of three stages of problem solving:
a) interpretation: the individual’s cognitive
representation of the illness in terms of
identity, cause, consequences, time line,
and availability
b) coping: the development of coping strate-
gies, which may constitute either approach,
in terms of seeking help, or avoidance, in
terms of denial
c) appraisal: the evaluation of coping strate-
gies and possible adoption of alternatives 
Models such as this have been applied to pre-
dict functioning in complaints such as CFS
with a moderate degree of success (7).
Application of health psychology and its
concepts to the field of risk assessment and
management, which is more usually the
domain of epidemiology and toxicology, is
perhaps less obvious. However, its relevance
becomes apparent when we consider
approaches to the investigation of symptom
reporting, one of the “softer” but neverthe-
less important outcome measures in health
research. Pennebaker (8) has argued convinc-
ingly that the human perceptual processes of
selectivity and interpretation that are opera-
tive regarding external stimuli also affect the
individual’s response to internal bodily activ-
ity. Thus, a range of factors may be impor-
tant in determining whether or not internal
body stimuli are attended to, how they are
interpreted, whether or not they are
reported, and whether they elicit a response,
medical or otherwise. These factors have
been summarized as follows (8):
•A  selective attention to body state that is
likely to be accentuated, a) where the exter-
nal environment is tedious and unstimulat-
ing, b) where communication with others
(which facilitates normalizing comparisons)
is limited or absent, c) where the environ-
ment is highly stressful but direct expression
of anxiety or depression and its source is
unacceptable, d) where individuals experi-
ence a sense of powerlessness, or e) where
there is a culture of illness expression.
• An attributional style that tends to be deter-
mined by the individual’s “mental models”
or schema, which are internal cognitive rep-
resentations of the world comprising our
attitudes and beliefs, by which we organize
and interpret our experiences.
• The mood-related disposition of negative
affectivity that appears to underpin the
more familiar personality factor of neuroti-
cism, characterized by an introspective ten-
dency to experience more distress and
dissatisfaction with both self and others and
to dwell on failures and shortcomings.
Models of symptom reporting that incorpo-
rate these factors tend to focus on individually
based determinants of subjective well-being
(9). From the point of view of occupational
and environmental epidemiology, however,
such models contain an important omission.
Information from external sources is
regarded as influential only in terms of
whether its absence or poor quality encour-
ages the individual to focus more narrowly
on internal states. Where the response to
hazard exposure is concerned, however, the
form and source of external information and
its social and cultural context are crucial ele-
ments in determining the interaction with
the individual’s particular mental models.
For example, communication with others
may in some circumstances act to focus an
individual’s attention on his or her internal
state and increase rather than reduce anxiety.
This aspect has been better addressed in the
field of risk perception, where attention is
drawn to the following factors (10):
• heightened concern about risk determined
by factors such as their involuntary, uncon-
trolled nature; lack of scientiﬁc information;
or particularly dreaded consequences
• prevailing levels of trust (or mistrust)
relating to government, industry, and
professional bodies
• prevailing attitudes and beliefs about med-
icine and other health-related professions
• the current political agenda
• the current legal agenda
• the current social and political climate
• current media and pressure group activity
The complex process of symptom reporting
therefore requires simultaneous consideration
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Figure 1. Two models of symptom reporting.
Main cause
Hazard exposure,
infection, etc.
Pathological changes
(disease)
Modifiers
Environmental, behavioral,
genetic
Traditional disease model Biopsychosocial model
Physical factors
Psychosocial factors
Symptoms
(illness)Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 603
of all these factors, which may be both
individually and socially determined.
The U.K. Sheep Dip Story
The Problem
Since 1976, sheep farmers in the United
Kingdom have been legally required to treat
their animals with a pesticide at least once a
year to control the widespread problem of
sheep scab, a serious and often fatal parasite-
borne disease that attacks the skin of the ani-
mals. Farmers were required to make up a
solution of pesticide concentrate and water in
a dip bath and immerse each animal in the
bath, thus soaking the ﬂeece and skin. During
this procedure, despite the specification of
various precautions, the farmers themselves
often become soaked in the solution, thus
experiencing pesticide exposure via both skin
absorption and inhalation. In 1984, because
of continuing problems with sheep scab, the
dipping requirement was increased to twice
yearly. That same year organochlorine-based
pesticides were banned in the United
Kingdom, leaving organophosphates as the
only realistic alternative. Soon after 1984
some farmers began to complain of symp-
toms of ill health that they associated with the
dipping process. Most frequently they
reported excessive fatigue, gastrointestinal
pain, headache, memory problems and
other cognitive confusion, depressed mood,
and feelings of anxiety. However, a compre-
hensive list of all symptoms reported at least
once contained no fewer than 67 items
(11). A proportion of the farmers claimed
that the symptoms did not disappear after
exposure had ceased and that they were
developing chronic ill health. From the
clinical and toxicologic point of view, this
raised some difficult issues:
• Symptoms reported immediately after
dipping were consistent with a well-under-
stood acute cholinergic response to
organophosphate exposure: mild flulike
symptoms. These symptoms are well
accepted clinically but would normally be
regarded as totally reversible. Persistent
chronic effects should not therefore occur.
• Biological monitoring (i.e., investigation of
changes in the farmers’ blood and plasma
cholinesterase levels during dipping) did not
suggest exposures occurring at levels likely
to result in these cholinergic responses.
•T here was no documented clinical evidence
of people experiencing long-term health
problems as a result of either one or several
episodes of high exposure, except perhaps in a
few patients who had experienced severe life-
threatening intoxication, and no such cases
had occurred as a result of sheep dipping.
• The persisting symptoms experienced by
the sufferers were diverse, lacking any
coherent pattern, and no pathological
changes could be identiﬁed.
These farmers therefore had developed an
“unexplained symptom syndrome.” They
proceeded to voice their complaints through
the media and via increasingly sophisticated
pressure group activity and persistent lobby-
ing of sympathetic members of Parliament.
Some individual farmers embarked on a series
of largely unsatisfactory encounters with
members of the medical profession in an
attempt to secure a diagnosis and/or treat-
ment, and a much smaller group achieved
some satisfaction in the law courts.
The government departments involved
were initially inclined to dismiss the problem,
basing their view on the available scientific
evidence. Subsequently, in response to public
pressure, they commissioned two large-scale
research projects (12,13), the first of which
was carried out by the author. Unfortunately,
the results appear only to have added to the
indecision and confusion surrounding this
issue. Essentially, because organophosphates
are established neurotoxins, and because of
the nature of most of the complaints, the
commissioned research focused on psycholog-
ical outcomes, notably, effects on cognitive
functioning and mental health. The assess-
ment of cognitive functioning, in particular,
created difﬁculties of interpretation for those
used to dealing with defined disease end
points. Functions such as attentional control
and information processing are measured on
a continuum, and any cutoff point denoting
impairment is likely to be, if not arbitrary, at
least dependent on the characteristics of the
population under study (age, educational
level, attitudes, motivation, etc.). Like symp-
tom reporting, performance on cognitive tests
represents the result of a complex interaction
of physical and psychological variables.
Hence, it was always going to be difﬁcult to
determine whether organophosphate expo-
sure “caused” signiﬁcant changes in cognitive
function by producing structural and func-
tional changes to the nervous system.
In a sense, the use of neurobehavioral
testing in this context represented an attempt
to harness psychological methods to the
medical model. In the absence of any identi-
fiable pathological changes that could be
measured more objectively, the disease end
point was to be deﬁned in terms of scores on
psychological tests. Operating within this
framework, the author’s study (12) did man-
age to isolate some subtle differences in cog-
nitive functioning between sheep farmers
and controls that remained after numerous
other potential influences on performance
had been adjusted or controlled for. Some of
these changes also appeared to be related to
the duration and intensity of exposure,
suggesting a dose–effect relationship.
However, because lowered psychological test
scores could not be said to constitute an iden-
tiﬁable disease, the regulatory authorities were
uneasy and skeptical. Moreover, they pointed
to the myriad psychosocial factors that might
inﬂuence the results as a reason for rejecting
the ﬁndings.
This response can perhaps be readily
understood when one considers the regula-
tory framework within which the government
department concerned (the then Ministry of
Agriculture) was required to operate. One of
its primary responsibilities was to act as a
licensing authority for veterinary medicines,
which included sheep dip. Hence, there was a
requirement to decide unequivocally whether
the substance in question was “safe” or
“unsafe” for use. Decisions of this nature are
more easily arrived at in the context of a dis-
ease/nondisease framework (i.e., a medical
model) than in situations where illness is ill-
defined and of multifactorial origin. The
impetus therefore is toward a rejection of
complex interpretations of the data and a
maintenance of the requirement for proof of
objectively veriﬁable organic disease.
This position tends to be reinforced by
the attendant liability implications. A particu-
lar feature of licensing authorities that is not
shared by other regulators in the United
Kingdom, such as the Health and Safety
Executive, is that the act of licensing effec-
tively transfers the legal responsibility for
safety from the consumer to the authority.
Thus, the consumers are absolved from such
responsibility provided they use only licensed
products and in the approved manner. This
factor is undoubtedly a strong determinant of
the decision-making approach of the regula-
tors and, perhaps more important in this con-
text, the attributional style of the consumers
when experiencing health problems. Further
licensing decisions tend to have at least an
outward appearance of risk removal (i.e.,
achievement of zero risk) rather than a more
realistic one of reducing risk to a level
deemed acceptable in societal terms. Again,
risk removal tends to be incompatible with
situations involving complex illnesses that are
difficult to define or quantify. Paradoxically
perhaps, the apparent adherence of both
farmers and policy makers first to a medical
model and then to a requirement for a zero-
risk situation produces a conﬂict that is difﬁ-
cult to resolve.
The initial research on organophosphate
sheep dip therefore served only to intensify
the controversy and antagonism between cam-
paigners and government, both of whom
claimed that the results supported their posi-
tion. Amidst continuing acrimonious debate,
the government commissioned further
research (13), this time requiring objectively
measurable outcomes (neurophysiological
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controversial psychological tests and symp-
tom questionnaires. The problem was once
more approached from the standpoint of the
medical model, and the results were again
unsatisfactory. Some similar subtle differences
in performance were observed but few, if any,
neurophysiological effects. The main outcome
of note was the demonstration of a signiﬁcant
association between symptom reporting and
handling of the organophosphate concentrate.
Although this provided an opportunity for a
minor policy decision (in this case improve-
ments to the concentrate container), it pro-
vided nothing in terms of disease deﬁnition,
diagnosis, or treatment and little more in
terms of informing risk management.
Over the last few years, this ongoing
research has been paralleled by the delibera-
tions of a number of government committees
and some officially commissioned evidence
reviews (14–16). An interim decision was
taken to withdraw the legal requirement to dip
sheep in 1992 but without a formal admission
that organophosphates represented a signifi-
cant risk to health—when used appropriately.
More recently, in 1999, organophosphate-
based dips were withdrawn from sale on a tem-
porary basis—in order to improve the
aforementioned concentrate containers. A few
months later sales were reinstated amidst rising
concern that sheep flocks were once more
being decimated by sheep scab.
At this point the problem is very far from
being resolved. A large number of farmers feel
they are suffering from a chronic and dis-
abling health problem that lacks even ofﬁcial
acknowledgment and for which they are
unable to get either treatment or compensa-
tion. Both the government and the medical
profession are experiencing indecision and
division on the subject, and future policy on
risk assessment and management of these
substances appears to be in some disarray.
Why Did the Farmers Become Ill?
Hindsight shows that a number of factors
were in place that together might predict the
situation:
• exposure to a chemical that is known to be
hazardous, associated with high dread con-
sequences, and for which the symptoms are
well documented
• modern farming practices that produce rela-
tive isolation of farmers in their working
and social lives and thus increase their
attention to internal states
• adverse economic circumstances that in
recent years have created major work and
life stressors for rural workers; risks of men-
tal health problems and suicide are known
to be signiﬁcantly elevated in this group
• prevailing negative social attitudes toward
chemicals in general and pesticides in
particular, as part of general environmental
concern; farmers may be viliﬁed by the pub-
lic because of pesticide use and experience
conflict between economic and social con-
cern, compounded by individual anxiety
about their own health
• the involuntary nature of the risk (legal
requirement) that offers the opportunity to
attribute blame externally; the problem
received very little public attention before
the introduction of mandatory dipping and
appears not to have become an issue in
other areas of agriculture where organo-
phosphates are used (e.g., orchard spraying)
•p revailing attitudes of mistrust toward gov-
ernment and industry
• lack of definite scientific information or
agreement among medical and other health
professionals
• interest and stimulation offered by the
media and social and emotional support
offered by pressure groups in contrast to a
prevailing attitude of skepticism among sec-
tions of mainstream medical opinion
Added to these factors, certain personality
variables are likely to explain some of the
individual differences in farmers’ responses.
It is important to reiterate at this point
that discussion of the determinants of symp-
tom reporting does not constitute a dismissal
of the farmer’s illness but simply a recogni-
tion that it is likely to result from a complex
interaction of physical, psychological, and
social processes. A similar picture can be iden-
tified in relation to numerous other condi-
tions, for example, sick building syndrome,
CFS, and the development of low back pain.
Future Directions
The failure of government-funded research
into the sheep dip problem to provide
answers that can inform policy represents one
example where conventional medical models
appear to be inappropriate. The biopsycho-
social approach has in fact gained some
acceptance in the context of individually
based treatments but has had much less inﬂu-
ence on the conduct of larger-scale group
investigations, and it is here where perhaps
most change is needed. It seems that where
we have unexplained symptom syndromes,
we must be prepared a) to have no objectively
measurable diagnostic criteria and to treat
perceived illness rather than demonstrable
organic disease as the focus of our investiga-
tion, b) to measure a wide range of factors
that may contribute interactively and to vary-
ing degrees—psychosocial factors are likely to
predominate here, and c) to accept the equal
importance of all these factors rather than
regarding most of them as “noise” in the data
to be controlled or adjusted for.
This approach would appear to have appli-
cation to a number of aspects of occupational
and environmental health practice, for
example,
• individual clinical investigations to deter-
mine the course of illness and define
treatment
• investigations of clusters or outbreaks of
symptoms
• population-based studies of attribution,
causation, and association
• the development of control strategies to
prevent harm at both organizational and
government levels
• the evaluation of the effectiveness of different
interventions
In terms of methodology, many of these
questions can be addressed by the adoption of
a traditionally quantitative approach, using
already existing questionnaire measures or
purpose-developed psychometric tools to
assess the various determinants of symptom
reporting. A number of powerful statistical
methods are available to address this type of
data in ways that explore the relationships
between different variables. For example,
structural equation modeling combines the
techniques of multiple regression and path
analysis for this purpose. A useful addition in
the future, however, might be greater use of
qualitative approaches that are becoming
increasingly popular in health-related
research (17). These methods, comprising
semistructured interviews and observational
techniques, are ideally suited to the in-depth
exploration of complex sets of interrelation-
ships and provide rich sets of data to comple-
ment quantitative information.
The biopsychosocial approach may help
to eliminate the need for sterile debates about
whether an illness is “real” and whether it is
“caused” by exposure to a particular agent
and allow us instead to address the various
needs of the sufferers as identiﬁed by the mul-
tiple contributory factors involved. The first
neurobehavioral study of sheep farmers (12)
found that in addition to lower scores on
some psychological tests, the farmers reported
significantly more symptoms of anxiety and
depression than the controls. As a follow-up
to this study, therefore, Jackson carried out a
further investigation of the various possible
determinants, including organophosphate
exposure, of the farmers’ poor mental health
(18). Five contributors to symptom reporting
were identiﬁed in this group, namely, person-
ality type, perceived fatigue, adverse life
events, dissatisfaction with the agricultural
lifestyle—and handling sheep less than 48 hr
after dipping. From a regulatory point of
view, it is entirely reasonable to focus on the
last factor (e.g., by advising avoidance of
sheep handling immediately after dipping),
and the occupational health regulators may
be said to have fulﬁlled their particular oblig-
ations at that point. However, they would
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no longer become ill as a result. Findings
such as these simply provide pointers as to
which aspects of the problem require inter-
vention and assistance from different profes-
sional groups, agencies, and policy makers.
Essentially, therefore, the issue is as much
one of attitude change among all those
involved as it is a question of methodology.
Most of us have an intuitive understanding
that how we feel physically, and what we
choose to say about our health is heavily inﬂu-
enced by our attitudes and beliefs, our mood,
and our motives. We tend to accept this read-
ily on a day-to-day basis while continuing to
downgrade the importance or validity of psy-
chological experiences when it comes to ques-
tions of disease. Witness the fierce desire of
those with symptom-based conditions for
recognition that they have a physical rather
than a psychological complaint—even where
the hazard in question is known to target the
brain. Presumably, this derives from a collec-
tive consciousness that dismisses or, worse,
attaches negative value judgments to psycho-
logical distress. Perhaps, therefore, the real
challenge is to change our own mental
models. This achieved, it might not be too
difﬁcult to incorporate what we in fact already
know into our scientiﬁc thinking and practice.
REFERENCES AND NOTES
1. Dembe AE. Occupation and Disease: How Social Factors
Affect the Conception of Work-related Disorders. New
Haven, CT:Yale University Press, 1996.
2. Spurgeon A, Gompertz DG, Harrington JM. Modifiers of
non-speciﬁc symptoms in occupational and environmental
syndromes. Occup Environ Med 53:361–366 (1996).
3. Engles C. The need for a new medical model: a challenge
for biomedicine. Science 196:129–136 (1977).
4. Ajzen I. From intentions to actions: a theory of planned
behaviour. In: Action-Control: From Cognition to Behaviour
(Kuhl J, Beckman J, eds). Berlin:Springer-Verlag, 1985;11–39.
5. Becker MH. The health belief model and personal health
behaviour. Health Educ Monogr 2:324–508 (1974).
6. Leventhal H, Nerenz D. The assessment of illness cogni-
tion. In: Measurement Strategies in Health Psychology
(Karoly P, ed). New York:John Wiley, 1985;517–554.
7. Moss-Morris R, Petrie K, Weinman J. Functioning in
chronic fatigue syndrome: do illness perceptions and
coping play a regulatory role? Br J Health Psychol
1:15–25 (1996).
8. Pennebaker JW. Psychological bases of symptom report-
ing: perceptional and emotional aspects of chemical sen-
sitivity. Toxicol Ind Health 4/5(10):497–511 (1994).
9. van Wijk CMTG, Kolk AM. Psychometric evaluation of
symptom perception related measures. Person Indiv Diff
1(20):55–70 (1996).
10. MacGregor DG, Fleming R. Risk perception and symptom
reporting. Risk Anal 6(16):773–783 (1996).
11. Jackson CA, Spurgeon A. Symptom-Reporting following
Occupational Exposure to Organophosphate Pesticides in
Sheep Dip. UK Health and Safety Executive, Contract
Research Report no. 371. Available: http://www.
hsebooks.co.uk [accessed 21 June 2002].
12. Stephens R, Spurgeon A, Calvert I, Beach J, Levy LS,
Berry H, Harrington JM. Neuropsychological effects of
long-term exposure to organophosphates in sheep dip.
Lancet 345:1135–1140 (1995).
13. Pilkington A, Jamal GA, Gilham R, Hansen S, Buchanan D,
Kidd M, Azis MA, Julu PO, Al-Rawas S, Ballantyne JP,
et al. Epidemiological Study of the Relationships between
Exposure to Organophosphate Pesticides and Indices of
Chronic Peripheral Neuropathy and Neuropsychological
Abnormalities in Sheep Farmers and Dippers. Report
TM/99/02c. Technical Memorandum Series. Edinburgh,
Scotland:Institute of Occupational Medicine, 1999.
14. Ray DE. Organophosphorous Esters: A Review of
Neurotoxic Effects. Report SR5. Leicester, UK:Institute for
Environment and Health, 1998.
15. Royal College of Physicians, Royal College of Psychiatrists.
Organophosphate Sheep Dip: Clinical Aspects of Long-
term Low-level Exposure. Report of a Joint Working Party.
London:Royal College of Physicians, 1998. 
16. Committee on Toxicity of Chemicals in Consumer Products
and the Environment. Organophosphates. London:UK
Department of Health, 1999.
17. Pope C. Qualitative research: reaching the parts other
methods cannot reach: an introduction to qualitative
methods in health and health services research. Br Med J
3(11):42–45 (1995).
18. Jackson CA. Unpublished data, 2001.
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 4 | AUGUST 2002 605
Unexplained Symptoms • Models of unexplained symptom syndromes